Tennessee Oncology Sues Genentech Over Cancer Drug Herceptin

Tennessee Oncology is suing biotechnology firm Genentech, alleging false representation in the packaging of a cancer drug.

The Nashville-based company claims the label and instructions for Herceptin, which is sold as a dehydrated and freeze-dried powder, misrepresent the amount of product in what is ultimately a breach of implied warranty and results in unjust enrichment for Genentech, in a lawsuit filed Friday in U.S. District Court for the Middle District of Tennessee,

Back to news